p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment - Concepedia

Concepedia

Publication | Closed Access

p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment

31

Citations

23

References

2010

Year

Regina Hecker, Ralf Amstutz, Marco Wachtel, Dagmar Walter, Felix Niggli, Beat W. Schäfer

Hdac InhibitorsOncogenic AgentMedicineCombination TreatmentTumor SuppressorPharmacologyCell BiologyNovel TherapyTumor BiologyP21 Downregulation

References

	Year	Citations

Page 1